<bill session="116" type="h" number="8467" updated="2023-01-11T13:44:51Z">
  <state datetime="2020-09-30">REFERRED</state>
  <status>
    <introduced datetime="2020-09-30"/>
  </status>
  <introduced datetime="2020-09-30"/>
  <titles>
    <title type="display">Access to Rare Indications Act of 2020</title>
    <title type="short" as="introduced">Access to Rare Indications Act of 2020</title>
    <title type="official" as="introduced">To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to provide for coverage of certain drugs used in the treatment or management of a rare disease or condition, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="T000460"/>
  <cosponsors>
    <cosponsor bioguide_id="K000376" joined="2020-09-30"/>
  </cosponsors>
  <actions>
    <action datetime="2020-09-30">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-09-30" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2020-09-30">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug therapy"/>
    <term name="Employee benefits and pensions"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Insurance industry and regulation"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2020-11-06T17:19:43Z" status="Introduced in House">Access to Rare Indications Act of 2020

This bill prohibits coverage exclusions or limitations under the Medicare prescription drug benefit, Medicaid, or private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals and that are supported by the National Institutes of Health Rare Diseases Clinical Research Network).</summary>
</bill>
